IO Biotech

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Total raised

€127M

€127,000,000

Funding rounds

Investors

distinct backers

Active since

2021-01

latest 2021-01

Funding by year

EUR raised per year

High confidence

Raise-next likelihood18

base rate 48% for Series B

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2021-01-13	Series B	€127M	HBM Healthcare Investments AG	View deal →

same sector or country